Related references
Note: Only part of the references are listed.How long should dual antiplatelet therapy be applied after covered stent implantation? A case report on clinical implications of left anterior descending artery aneurysm treatment with covered stent implantation
Eugeniusz Hrycek et al.
KARDIOLOGIA POLSKA (2023)
Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project
Wen-Hua Li et al.
CLINICAL CARDIOLOGY (2017)
Comparative risk of major bleeding with new oral anticoagulants (NOACs) and phenprocoumon in patients with atrial fibrillation: a post-marketing surveillance study
Stefan H. Hohnloser et al.
CLINICAL RESEARCH IN CARDIOLOGY (2017)
Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation Systematic Review and Meta-Analysis
Ying Bai et al.
STROKE (2017)
The transient intraluminal filament middle cerebral artery occlusion model as a model of endovascular thrombectomy in stroke
Brad A. Sutherland et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type
Duncan Wilson et al.
NEUROLOGY (2016)
Grapefruit Derived Flavonoid Naringin Improves Ketoacidosis and Lipid Peroxidation in Type 1 Diabetes Rat Model
Alfred N. Murunga et al.
PLOS ONE (2016)
Pretreatment with rivaroxaban attenuates stroke severity in rats by a dual antithrombotic and anti-inflammatory mechanism
Melanie Dittmeier et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin A propensity score matched analysis
Gregory Y. H. Lip et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Bleeding risk higher with rivaroxaban than dabigatran for stroke prevention, head-to-head trial shows
Ingrid Torjesen
BMJ-BRITISH MEDICAL JOURNAL (2016)
Bleeding risk higher with rivaroxaban than dabigatran for stroke prevention, head-to-head trial shows
Ingrid Torjesen
BMJ-BRITISH MEDICAL JOURNAL (2016)
Newer Oral Anticoagulants: Stroke Prevention and Pitfalls
Anand Patel et al.
OPEN CARDIOVASCULAR MEDICINE JOURNAL (2016)
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
Jeffrey L. Saver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
M. Goyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
O. A. Berkhemer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2015)
Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients
Raul G. Nogueira et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2015)
Predictors of Outcome and Hemorrhage in Patients Undergoing Endovascular Therapy with Solitaire Stent for Acute Ischemic Stroke
Shaowei Jiang et al.
PLOS ONE (2015)
Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke
Robert Ploen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Revascularization for Acute Ischemic Stroke Is Safe for Rivaroxaban Users
Satoshi Kimura et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)
Rivaroxaban and Apixaban Reduce Hemorrhagic Transformation After Thrombolysis by Protection of Neurovascular Unit in Rat
Syoichiro Kono et al.
STROKE (2014)
Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes
Aisha I. Kelly-Cobbs et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Stroke prevention in atrial fibrillation-An Asian stroke perspective
Hung-Fat Tse et al.
HEART RHYTHM (2013)
Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With Rivaroxaban
Wei Zhou et al.
STROKE (2013)
No Influence of Dabigatran Anticoagulation on Hemorrhagic Transformation in an Experimental Model of Ischemic Stroke
Ferdinand Bohmann et al.
PLOS ONE (2012)
Cerebrovascular Complications of Diabetes: Focus on Stroke
Adviye Ergul et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2012)
Activated Blood Coagulation Factor X (FXa) Induces Angiogenic Growth Factor Expression in Human Retinal Pigment Epithelial Cells
Margrit Hollborn et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Endovascular Stroke Treatment Today
I. Q. Grunwald et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Neurovascular Injury in Acute Hyperglycemia and Diabetes: a Comparative Analysis in Experimental Stroke
Mostafa M. Elgebaly et al.
TRANSLATIONAL STROKE RESEARCH (2011)
Adaptive Cerebral Neovascularization in a Model of Type 2 Diabetes Relevance to Focal Cerebral Ischemia
Weiguo Li et al.
DIABETES (2010)
Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
A. John Camm et al.
EUROPACE (2010)
HYDROGEN GAS REDUCED ACUTE HYPERGLYCEMIA-ENHANCED HEMORRHAGIC TRANSFORMATION IN A FOCAL ISCHEMIA RAT MODEL
C. H. Chen et al.
NEUROSCIENCE (2010)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
PLOS BIOLOGY (2010)
Disruptions of Occludin and Claudin-5 in Brain Endothelial Cells In Vitro and in Brains of Mice with Acute Liver Failure
Feng Chen et al.
HEPATOLOGY (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Death and disability from warfarin-associated intracranial and extracranial hemorrhages
Margaret C. Fang et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Heart disease and stroke statistics - 2007 update - A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Wayne Rosamond et al.
CIRCULATION (2007)
Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice
DK Gao et al.
LIFE SCIENCES (2006)
Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes
AB El-Remessy et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
The blood-brain barrier/neurovascular unit in health and disease
BT Hawkins et al.
PHARMACOLOGICAL REVIEWS (2005)
Effects of Isoflurane on gastrointestinal motility after brief exposure in rats
MC Torjman et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Targets for vascular protection after acute ischemic stroke
SC Fagan et al.
STROKE (2004)
Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome
TA Baird et al.
STROKE (2003)
Cerebral microvessel responses to focal ischemia
GJ del Zoppo et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke
J Montaner et al.
STROKE (2001)
Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia
M Asahi et al.
JOURNAL OF NEUROSCIENCE (2001)
Influence of buprenorphine analgesia on post-operative recovery in two strains of rats
P Jablonski et al.
LABORATORY ANIMALS (2001)
Hemorrhagic transformation after fibrinolysis with tissue plasminogen activator - Evaluation of role of hypertension with rat thromboembolic stroke model
E Tejima et al.
STROKE (2001)
Share Paper
